June 13th 2025
Both oral and subcutaneous formulations of the long-acting GLP-1 and amylin receptor agonist move into stage 3 clinical trials following positive feedback from regulators.
American Academy of Pediatrics Landmark Obesity Guidelines Recommend Proactive, Aggressive Approach
January 9th 2023The comprehensive recommendations are the first in 15 years and focus on early evaluation and aggressive treatment that includes family support and accommodates social determinants of health.